Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03292159 · ClinicalTrials.gov registry record · Phase 1
Transcutaneous Vagus Nerve Stimulation for Motor Recovery After Stroke
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT03292159: Clinical Trial Phase 1 study, sponsored by Massachusetts General Hospital.
NCT03292159 is a Phase 1 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03292159, a Phase 1 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study will evaluate the safety and effectiveness of Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) for improving motor recovery after stroke. Subacute stroke patients will receive RAVANS or sham stimulation concurrent with arm motor training during 10 intervention sessions occurring daily for 30 minutes over 2 weeks. The safety and improvements in arm motor function after the intervention will be compared in patients receiving RAVANS to those receiving sham stimulation.
Interventions
- DEVICE Active RAVANS concurrent with arm motor training
- DEVICE Inactive RAVANS concurrent with arm motor training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-05-17 |
| Est. Completion | 2018-11-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03292159
The ClinicalTrials.gov registry entry for NCT03292159 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active RAVANS concurrent with arm motor training is the first listed.
NCT03292159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03292159 about?
NCT03292159 is a clinical study titled "Transcutaneous Vagus Nerve Stimulation for Motor Recovery After Stroke". This study will evaluate the safety and effectiveness of Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) for improving motor recovery after stroke. Subacute stroke patients will receive RAVANS or sham stimulation concurrent with arm motor training during 10 intervention session...
What is the current status of trial NCT03292159?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2018-05-17. Estimated completion is 2018-11-20.
What interventions are being tested in trial NCT03292159?
The interventions under investigation include: Active RAVANS concurrent with arm motor training (DEVICE), Inactive RAVANS concurrent with arm motor training (DEVICE).
Who is sponsoring clinical trial NCT03292159?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.